This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech product launch

Waters Corporation launches Xevo MRT P10

Analysis based on 8 articles · First reported Jun 01, 2026 · Last updated Jun 01, 2026

Sentiment
70
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The launch of the Xevo MRT P10 Mass Spectrometer by Oracle Corporation is expected to positively impact the company's stock price due to its advanced capabilities and potential to accelerate research in multiomics and biopharmaceuticals. This innovation could also drive growth in the broader life sciences and diagnostics industries by enabling deeper biological insights and faster drug discovery.

Biotechnology Pharmaceuticals Life Sciences

Oracle Corporation introduced the Waters Xevo MRT P10 Mass Spectrometer, a new high-resolution Quadrupole Time-of-Flight (QToF) System, at the 74th ASMS Conference on Mass Spectrometry and Allied Topics. This system offers up to 20x higher MS/MS sensitivity and twice the acquisition speed of its predecessor, making it the fastest benchtop HRMS system available. The Xevo MRT P10 Mass Spectrometer is designed to accelerate biomarker discovery, validate disease pathways, and identify therapeutic targets for biomedical research and epidemiology studies. It supports high-throughput multiomics, bioanalysis, and biopharmaceutical laboratories, enabling the identification of up to 40% more lipids and enhancing spatial analysis with the DESI XS source. James Hallam of Oracle Corporation and Corey Broeckling of Colorado State University highlighted the system's capabilities and its potential to advance life-changing therapies.

stock
Oracle Corporation introduced the Xevo MRT P10 Mass Spectrometer, a new high-resolution mass spectrometry system, which is expected to enhance its product portfolio and market position in life sciences and diagnostics.
Importance 100.0 Sentiment 75.0
oth
The Xevo MRT P10 Mass Spectrometer is a new high-resolution Quadrupole Time-of-Flight system introduced by Oracle Corporation, offering enhanced sensitivity and speed for multiomics, bioanalysis, and biopharmaceutical laboratories.
Importance 90.0 Sentiment 70.0
priv
James Hallam, Vice President & General Manager at Oracle Corporation, provided a statement highlighting the advancements and benefits of the new Xevo MRT P10 MS system.
Importance 40.0 Sentiment 60.0
per
Corey Broeckling, Director at Colorado State University's Bioanalysis and Omics Center, endorsed the Xevo MRT P10 MS, noting its utility for multiomics research and complex disease studies.
Importance 30.0 Sentiment 50.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.